Lepirudin API | Recombinant Direct Thrombin Inhibitor API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Lepirudin API

Lepirudin is a recombinant hirudin analogue and a direct thrombin inhibitor. It binds directly and specifically to thrombin, inhibiting its enzymatic activity and preventing the conversion of fibrinogen to fibrin.

Lepirudin was developed from hirudin, a naturally occurring anticoagulant originally identified in medicinal leeches. It is a peptide-based biological pharmaceutical ingredient used as an anticoagulant in specific clinical settings.

Lepirudin API Manufacturer in India

Lepirudin is a specialized peptide/biological pharmaceutical API requiring controlled recombinant production, purification and extensive biological and physicochemical characterization.

Important quality attributes include identity, purity, peptide integrity, biological activity, aggregation, host-cell proteins, residual DNA, endotoxins, bioburden and sterility.

Biological Information

CAS Number: 138068-37-8
Molecular Formula: C287H440N80O110S6
Molecular Weight: Approximately 6963.3 Da
Drug Class: Anticoagulant
Pharmacological Class: Direct Thrombin Inhibitor
Therapeutic Class: Antithrombotic Agent
Therapeutic Area: Hematology / Cardiovascular

Mechanism of Action

Lepirudin binds directly to thrombin, including both its catalytic site and fibrin-binding region.

Thrombin is a central enzyme in the coagulation cascade. By inhibiting thrombin, lepirudin reduces:

  • Conversion of fibrinogen to fibrin
  • Thrombin-mediated platelet activation
  • Formation and propagation of blood clots
  • Thrombin-dependent coagulation activity

Pharmaceutical Applications

Lepirudin has been used as an anticoagulant in patients with heparin-induced thrombocytopenia (HIT) and associated thrombotic complications.

Its clinical use and availability depend on the applicable regulatory status and local treatment guidelines.

Recombinant Hirudin Characteristics

Lepirudin is structurally related to hirudin, a highly specific natural thrombin inhibitor. Unlike heparin, which enhances the activity of antithrombin, lepirudin acts by directly binding to thrombin.

This direct mechanism makes it pharmacologically distinct from indirect anticoagulants.

Manufacturing Process

Typical recombinant production may involve:

  1. Recombinant expression of the peptide/protein
  2. Cell-culture or microbial fermentation
  3. Harvest and clarification
  4. Purification
  5. Protein/peptide concentration
  6. Chromatographic purification
  7. Removal of process-related impurities
  8. Formulation
  9. Sterile filtration
  10. Aseptic processing
  11. Final analytical testing
  12. Controlled packaging

Quality and Analytical Testing

Lepirudin quality evaluation may include:

  • Identity testing
  • Peptide mapping
  • Molecular-weight determination
  • Purity
  • Related proteins/peptides
  • Aggregates
  • Biological potency
  • Thrombin inhibitory activity
  • Host-cell protein
  • Residual host-cell DNA
  • Endotoxins
  • Bioburden
  • Sterility
  • Subvisible particles
  • Stability testing

Storage

Lepirudin should be stored according to validated stability data and approved product requirements. Temperature control and protection from inappropriate environmental conditions are important for maintaining peptide/protein stability.

Pharmaceutical Research and Development

Lepirudin is relevant to research involving:

  • Thrombin inhibition
  • Blood coagulation
  • Direct thrombin inhibitors
  • Heparin-induced thrombocytopenia
  • Anticoagulant therapy
  • Hirudin analogues
  • Thrombosis
  • Hematology
  • Peptide therapeutics
  •  

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Individual Impurity NMT 0.5%
Total Impurities NMT 2.0%
Water Content NMT 1.0%
Get Bulk Quote via WhatsApp